BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 22408582)

  • 1. Generational association studies of dopaminergic genes in reward deficiency syndrome (RDS) subjects: selecting appropriate phenotypes for reward dependence behaviors.
    Blum K; Chen AL; Oscar-Berman M; Chen TJ; Lubar J; White N; Lubar J; Bowirrat A; Braverman E; Schoolfield J; Waite RL; Downs BW; Madigan M; Comings DE; Davis C; Kerner MM; Knopf J; Palomo T; Giordano JJ; Morse SA; Fornari F; Barh D; Femino J; Bailey JA
    Int J Environ Res Public Health; 2011 Dec; 8(12):4425-59. PubMed ID: 22408582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute intravenous synaptamine complex variant KB220™ "normalizes" neurological dysregulation in patients during protracted abstinence from alcohol and opiates as observed using quantitative electroencephalographic and genetic analysis for reward polymorphisms: part 1, pilot study with 2 case reports.
    Miller DK; Bowirrat A; Manka M; Miller M; Stokes S; Manka D; Allen C; Gant C; Downs BW; Smolen A; Stevens E; Yeldandi S; Blum K
    Postgrad Med; 2010 Nov; 122(6):188-213. PubMed ID: 21084795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reward deficiency syndrome: genetic aspects of behavioral disorders.
    Comings DE; Blum K
    Prog Brain Res; 2000; 126():325-41. PubMed ID: 11105655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurogenetics of dopaminergic receptor supersensitivity in activation of brain reward circuitry and relapse: proposing "deprivation-amplification relapse therapy" (DART).
    Blum K; Chen TJ; Downs BW; Bowirrat A; Waite RL; Braverman ER; Madigan M; Oscar-Berman M; DiNubile N; Stice E; Giordano J; Morse S; Gold M
    Postgrad Med; 2009 Nov; 121(6):176-96. PubMed ID: 19940429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Some ADHD polymorphisms (in genes DAT1, DRD2, DRD3, DBH, 5-HTT) in case-control study of 100 subjects 6-10 age.
    Kopecková M; Paclt I; Petrásek J; Pacltová D; Malíková M; Zagatová V
    Neuro Endocrinol Lett; 2008 Apr; 29(2):246-51. PubMed ID: 18404133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A pharmacogenetic analysis of dopaminergic and opioidergic genes in opioid addicts treated with the combination of naltrexone and guanfacine].
    Kibitov АО; Krupitsky ЕМ; Blokhina ЕА; Verbitskaya ЕV; Brodyansky VМ; Alekseeva NP; Bushara NМ; Yaroslavtseva ТS; Palatkin VY; Masalov DV; Burakov АМ; Romanova ТN; Sulimov GY; Grinenko AY; Kosten Т; Nielsen D; Zvartau EE
    Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(11. Vyp. 2):36-48. PubMed ID: 28300812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association study between the DAT1, DBH and DRD2 genes and cocaine dependence in a Spanish sample.
    Fernàndez-Castillo N; Ribasés M; Roncero C; Casas M; Gonzalvo B; Cormand B
    Psychiatr Genet; 2010 Dec; 20(6):317-20. PubMed ID: 20505554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overcoming qEEG abnormalities and reward gene deficits during protracted abstinence in male psychostimulant and polydrug abusers utilizing putative dopamine D₂ agonist therapy: part 2.
    Blum K; Chen TJ; Morse S; Giordano J; Chen AL; Thompson J; Allen C; Smolen A; Lubar J; Stice E; Downs BW; Waite RL; Madigan MA; Kerner M; Fornari F; Braverman ER
    Postgrad Med; 2010 Nov; 122(6):214-26. PubMed ID: 21084796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Candidate system analysis in ADHD: evaluation of nine genes involved in dopaminergic neurotransmission identifies association with DRD1.
    Ribasés M; Ramos-Quiroga JA; Hervás A; Sánchez-Mora C; Bosch R; Bielsa A; Gastaminza X; Lesch KP; Reif A; Renner TJ; Romanos M; Warnke A; Walitza S; Freitag C; Meyer J; Palmason H; Casas M; Bayés M; Cormand B
    World J Biol Psychiatry; 2012 Apr; 13(4):281-92. PubMed ID: 22404661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association analysis between polymorphisms in the dopamine D2 receptor (DRD2) and dopamine transporter (DAT1) genes with cocaine dependence.
    Lohoff FW; Bloch PJ; Hodge R; Nall AH; Ferraro TN; Kampman KM; Dackis CA; O'Brien CP; Pettinati HM; Oslin DW
    Neurosci Lett; 2010 Apr; 473(2):87-91. PubMed ID: 20170711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies of the potential role of the dopamine D1 receptor gene in addictive behaviors.
    Comings DE; Gade R; Wu S; Chiu C; Dietz G; Muhleman D; Saucier G; Ferry L; Rosenthal RJ; Lesieur HR; Rugle LJ; MacMurray P
    Mol Psychiatry; 1997 Jan; 2(1):44-56. PubMed ID: 9154217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influences of polymorphic variants of DRD2 and SLC6A3 genes, and their combinations on smoking in Polish population.
    Sieminska A; Buczkowski K; Jassem E; Niedoszytko M; Tkacz E
    BMC Med Genet; 2009 Sep; 10():92. PubMed ID: 19761593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between dopaminergic neurotransmission, alcoholism, and Reward Deficiency syndrome.
    Bowirrat A; Oscar-Berman M
    Am J Med Genet B Neuropsychiatr Genet; 2005 Jan; 132B(1):29-37. PubMed ID: 15457501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular neurological correlates of endorphinergic/dopaminergic mechanisms in reward circuitry linked to endorphinergic deficiency syndrome (EDS).
    Blum K; Baron D; McLaughlin T; Gold MS
    J Neurol Sci; 2020 Apr; 411():116733. PubMed ID: 32088516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polygenic inheritance of Tourette syndrome, stuttering, attention deficit hyperactivity, conduct, and oppositional defiant disorder: the additive and subtractive effect of the three dopaminergic genes--DRD2, D beta H, and DAT1.
    Comings DE; Wu S; Chiu C; Ring RH; Gade R; Ahn C; MacMurray JP; Dietz G; Muhleman D
    Am J Med Genet; 1996 May; 67(3):264-88. PubMed ID: 8725745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Family-based association studies of bipolar disorder with candidate genes involved in dopamine neurotransmission: DBH, DAT1, COMT, DRD2, DRD3 and DRD5.
    Kirov G; Jones I; McCandless F; Craddock N; Owen MJ
    Mol Psychiatry; 1999 Nov; 4(6):558-65. PubMed ID: 10578238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Family-based and case-control study of DRD2, DAT, 5HTT, COMT genes polymorphisms in alcohol dependence.
    Samochowiec J; Kucharska-Mazur J; Grzywacz A; Jabłoński M; Rommelspacher H; Samochowiec A; Sznabowicz M; Horodnicki J; Sagan L; Pełka-Wysiecka J
    Neurosci Lett; 2006 Dec; 410(1):1-5. PubMed ID: 17079080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Family based association study of DRD1, DRD2, DRD3, DRD4, DAT, COMT gene polymorphism in schizophrenia].
    Paweł K; Hauser J; Skibińska M; Szczepankiewicz A; Dmitrzak-Weglarz M; Gorzkowska K; Pawlak J; Czerski PM
    Psychiatr Pol; 2010; 44(3):405-13. PubMed ID: 20672519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopaminergic Genetic Variants and Voluntary Externally Paced Exercise Behavior.
    VAN DER Mee DJ; Fedko IO; Hottenga JJ; Ehli EA; VAN DER Zee MD; Ligthart L; VAN Beijsterveldt TCEM; Davies GE; Bartels M; Landers JG; DE Geus EJC
    Med Sci Sports Exerc; 2018 Apr; 50(4):700-708. PubMed ID: 29135816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation instead of blocking mesolimbic dopaminergic reward circuitry is a preferred modality in the long term treatment of reward deficiency syndrome (RDS): a commentary.
    Blum K; Chen AL; Chen TJ; Braverman ER; Reinking J; Blum SH; Cassel K; Downs BW; Waite RL; Williams L; Prihoda TJ; Kerner MM; Palomo T; Comings DE; Tung H; Rhoades P; Oscar-Berman M
    Theor Biol Med Model; 2008 Nov; 5():24. PubMed ID: 19014506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.